Reference ID: 3101735
for the adjuvant treatment of patients with operable node-positive breast cancer. 1.2 Non-Small Cell Lung Cancer . Docetaxel Injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy.
Download Reference ID: 3101735
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Tablets, Antidepressant, Effexor, Venlafaxine hydrochloride, Venlafaxine, Hydrochloride
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
Administration, Drug, Food and drug administration, Food, Cytotec
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
Clinical, Capsule, Hydrochloride, Namenda xr, Namenda, Memantine hydrochloride, Memantine
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
Drug, Food, Food and drug, Only, Intravenous, For intravenous use only
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
Alcohols, Neonates, Contains, In neonates contains benzyl, Benzyl, In neonates contains benzyl alcohol
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Administration, Drug, Food and drug administration, Food, Only, Venofer
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
EN-2890 Vancomycin Hydrochloride for Injection, …
www.accessdata.fda.govbacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed.
Injection, Hydrochloride, Vancomycin, Vancomycin hydrochloride for injection
Related documents
PREVENTIVE CARE SAVES LIVES - BCBSM
www.bcbsm.comLung cancer screening Based on individual risk Ask your doctor Mammogram (breast exam/cancer screening) Women, 50 to 74 Every two years Osteoporosis screening (brittle bones) Women 50 to 64 Women 65 and older Ask your doctor At least one bone scan Pap smear (cervical cancer screening) — not recommended for
NCCN Clinical Practice Guidelines in Oncology NCCN ...
www2.tri-kobe.orgUpdates in Version 2.2020 of the NCCN Guidelines for Non-Small Cell Lung Cancer from Version 1.2020 include: NSCL-19 • The following regimens added for the first-line treatment of patients with metastatic NSCLC and an EGFR mutation. Erlotinib + ramucirumab as an "other recommended" treatment option as a category 2A.
Guidelines, Lungs, Cancer, Nccn, Nccn guidelines, Lung cancer
Lung cancer - WHO
www.who.intber of deaths from lung cancer in less developed countries is steadily increasing. While historically more men than women have died from lung cancer as a result of higher levels of smoking, the male:female mortality ratio is now showing signs of narrow-ing. Both sex- and gender-linked fac-tors are important in the etiology of lung cancer.
Cancer Facts & Figures 2019
www.cancer.orgby comparing cancer occurrence in people with a certain exposure or trait to cancer occurrence in people without this characteristic. For example, men and women who smoke are about 25 times more likely to develop lung cancer than nonsmokers, so the relative risk of lung cancer among smokers is 25. Most relative risks are not this large.
Women and Smoking
www.cdc.govDISEASE AND WOMEN SMOKERS. Many of the findings in the 2014 Surgeon General’s Report are especially im-portant for women who smoke. Between 1959 and 2010, lung cancer risk for smokers rose dramatically. While men’s risk doubled, the risk among female smokers increased nearly ten-fold. Today, more women die from lung cancer than breast cancer.
Cancer Facts & Figures for African Americans 2019-2021
www.cancer.orgCancer Facts & Figures for African Americans 2019-2021 3 Screening can prevent colorectal and cervical cancers through the detection and removal of precancerous growths and can also reduce mortality for cancers of the breast, colon, rectum, cervix, prostate, and lung (among current or former heavy smokers) through early detection.
American, Fact, Lungs, 2019, African, Figures, Cancer, Cancer facts amp figures for african americans 2019, And lung
Cancer Screening MOH 140510
www.moh.gov.sglung cancer is not recommended (pg 35). Grade A, Level 1+ C The use of low-dose CT scan to screen for lung cancer outside the context of a clinical trial is not recommended (pg 35). Grade C, Level 2+ Screening for breast cancer in women A All normal risk, asymptomatic women 50-69 years of age should be screened with mammography only, every two ...